Dear reader of, please excuse the disruption. needs about $63500 in 2024. In 2023 we received donations of about $ 32200. Unfortunately, 99.8% of our readers do not donate. If everyone who reads this request makes a small contribution, our fundraising campaign for 2024 would be over after a few days. This donation request is displayed 23,000 times a week, but only 75 people donate. If you find useful, please take a minute and support with your donation. Thank you!

Since 01.06.2021 is supported by the non-profit ADxS e.V..

$8975 of $63500 - as of 2024-02-29
Header Image
Neurophysiological mechanisms of action on behavior through immune reactions


Neurophysiological mechanisms of action on behavior through immune reactions

The stress hormones of the HPA axis (CRH, vasopressin, ACTH) not only mediate immune responses, but also behavioral responses. These behavioral triggers of the stress hormones explain some of the ADHD symptoms, but probably not all of them.
Proinflammatory and anti-inflammatory cytokines of the immune system, which are activated by the various stress hormones, also have behavioral aspects. The mediation of behavioral effects by inflammatory responses is based on various neurophysiological mechanisms. These include glial cell activation, neuronal damage, increased oxidative stress, decreased BDNF levels, blood-brain barrier disruption and altered neurotransmitter metabolism such as serotonin, dopamine, noradrenaline and glutamate. The effects on these systems lead to changes in motivation, motor function, anxiety, arousal and alertness.
Inflammation has a direct influence on the dopaminergic system and reduces dopamine levels in the brain. Dopamine in turn influences the release of inflammation-related cytokines. Inflammatory processes can cause oxidative stress and neurotoxic effects via the glutamate balance. A deficiency of tetrahydrobiopterin (BH4), an enzyme cofactor required for the synthesis of serotonin and dopamine, can lead to an impairment of serotonin synthesis.

Inflammatory markers are elevated in a number of neuropsychiatric disorders:1

  • ADHD
  • ASS
  • Depression
  • Bipolar disorder
  • Post-traumatic stress disorder (PTSD)
  • Obsessive-compulsive disorder
  • Tourette’s disorder
  • Schizophrenia

Correlations were also found between atopic immune system conditions and ADHD.2

An increased reaction intensity of the immune system could lead to greater withdrawal behavior.3 Immune system activation due to infections leads to social withdrawal.4 In people with high social withdrawal behavior, a (very small) study found increased immune activation of proinflammatory cytokines with decreased B-lymphocyte function and IFN-α response. Anti-inflammatory glucocorticoid response elements were decreased and response elements for proinflammatory NF-κBRel transcription factors were increased.5 This could be explained evolutionarily by the fact that a higher reactivity of the immune system costs more resources. Since every activation of the immune defense requires effort, it would be logical if individuals with a more easily/quickly activated immune defense tend to keep their distance from infection foci (other individuals) than those with a lower risk of (costly) immune system activation. From this it could be concluded that social phobia correlates with an easily activated immune system.
However, individuals with high extraversion have a more activated immune system than individuals with high agreeableness. Another study found increased pro-inflammatory gene expression for extraversion, while it was reduced for conscientiousness.6

1. Neurophysiological mechanisms of the mediation of behavioral effects by inflammatory reactions

The basic neurophysiological mechanisms of the mediation of behavioral effects by inflammatory reactions are discussed:7

  • Glial activation8
  • Neuronal damage and neurodegeneration9
  • Increased oxidative stress10
  • Reduced BDNF levels11
  • Disorders of the blood-brain barrier12
  • Altered neurotransmitter metabolism13

2. Behavioral changes due to cytokine effects on neurotransmitters

Inflammation affects various neurotransmitter systems of the brain, including serotonin, dopamine, norepinephrine and glutamate pathways, as well as the kynurenine pathway, which produces the neurotoxic metabolite quinolinic acid. Disruptions in neurotransmitter systems correlate with inflammation-induced changes that mediate motivation and motor function as well as anxiety, arousal and alarm.1415

The innate immune system and pro-inflammatory cytokines have a direct influence on dopamine in the basal ganglia, thereby influencing motivation (reduction) and motor skills (slowing down).1617 Inflammatory reactions cause a preference for avoiding losses over achieving gains.18 Endotoxin reduces the activity of the striatum in response to offered rewards.19

Dopamine transporters, which are prominently involved in the pathogenesis of ADHD, are abundant on human T cells.20
In STAT6-deficient mice, DAT in the striatum is reduced, inducing hyperactivity (where STAT6 interacts closely with cytokines and growth factors).21

Dopamine has the unusual property of triggering the upregulation of cytokines by 500%:22

  • TNFα within 24 hours, via the D3 receptor
  • IL-10 within 72 hours, via the D2 receptor
  • TNFα within 24 hours and IL-10 within 72 hours via the D1 / D5 receptors
  • IFN-γ remained unchanged
  • IL-4 remained unchanged

Inflammation and disease put a strain on working memory by reducing the ability of short-term memory to process environmental stimuli. This effect is probably responsible for the changes in cognition caused by inflammation.4 In ADHD, working memory is significantly impaired.

3. Inflammatory processes and dopamine

Much of the description of the link between the inflammatory elements of the immune system and dopamine is based on Felger’s work.23

Inflammatory processes have a direct influence on the dopaminergic system.

3.1. Pro-inflammatory cytokines cause

  • Reduced reactions of the ventral striatum to hedonic reward stimuli (anhedonia)2324
  • Reduced dopamine levels in the striatum23
  • Reduced levels of dopamine and dopamine metabolites in the cerebrospinal fluid23
  • Reduced functional connectivity of striatal reward systems due to CRP, IL-6, IL-1beta and IL-1 RA.232517 Reduced connectivity between brain areas is thought to be a (co-)cause of ADHD and is improved by stimulants. More on this at ⇒ ** Effect on connectivity between brain regions in the articleMethylphenidate (MPH) for ADHD.

3.1.1. Behavioral symptoms due to pro-inflammatory cytokines

The effects of pro-inflammatory cytokines correlate with (depressive) behavioral symptoms

  • Anhedonia2324
  • Tiredness23
  • Psychomotor deceleration2324

3.1.2. Cytokine effects on the dopamine system

Cytokines act on the dopamine system through various mechanisms. Reduction of tetrahydrobiopterin (BH4) inhibits dopamine synthesis

BH4 is therefore essential for the synthesis of serotonin, noradrenaline and dopamine.

Dopamine is synthesized from phenylanaline (via the enzyme phenylanaline hydroxlase) to tyrosine, which is synthesized (via the enzyme tyrosine hydroxlase) to L-dopa and from there to dopamine.
Tetrahydrobiopterin (BH4) is involved (as an enzyme cofactor of tyrosine hydroxlase) in the synthesis of tyrosine from phenylanaline and (as an enzyme cofactor of phenylanaline hydroxlase) in the synthesis of L-dopa from tyrosine. Dopamine is in turn a precursor of noradenalin.
A lack of BH4 thus impairs the synthesis of dopamine (and noradrenaline).
Vitamin B12 supports the generation of tetrahydrobiopterin (BH4).

Inflammation and cytokines, e.g. IFN-alpha, can reduce the availability of BH4.2627 This impairs the synthesis of dopamine and serotonin.

Inflammation increases the activity of inducible NOS (iNOS), which binds BH4 (which acts as a cofactor for nitric oxide synthases (NOS)). This causes the formation of ROS (oxygen radicals) instead of NO.28 BH4 thus regulates the formation of superoxides.29 ROS cause oxidative stress, which in turn contributes to the oxidative reduction of BH4 itself. BH4 oxidizes very easily.28
These mechanisms reduce BH4 availability, which limits dopamine synthesis.28

Peripherally injected IFN-α lowers BH4 levels in the amygdala and raphe nuclei of rats by increasing NO synthesis. When NO synthesis is inhibited, IFN-α loses its inhibitory effect on BH4 and dopamine levels in the brain.30

Cardiotrophin-1 (CT-1) as well as ciliary neurotrophic factor (CNTF) reduced BF4 levels in nerve cells by 90 %, while IL-6 or TNF-alpha did not cause any significant change in BF4.31

In ADHD, dopamine synthesis (e.g. via BH4) does not appear to be impaired, as the administration of L-dopa has no effect on ADHD symptoms. Increase in tyrosine hydroxylase

An increase in tyrosine hydroxylase due to IL-1-beta indicates increased dopamine turnover in the hypothalamus. The change correlated with increased ACTH levels with unchanged prolactin levels.32 Reduced expression or effect of VMAT2 promotes oxidative stress

The vesicular monoamine transporter (VMAT, VMAT2) is involved in the storage of dopamine in the vesicles. There are sex differences in neuronal VMAT2 activity that explain the different response to methamphetamine. Packaging of dopamine in dopaminergic neurons by VMAT2 is required to prevent damage from oxidized dopamine during oxidative stress or after methamphetamine intake. Mice with only 5 to 10 % VMAT2 showed rapid damage to such neurons.33 Increased expression or effect of DAT Increased expression or effect of DAT by VMAT and MAPK

Dopamine transporters have the task of reabsorbing dopamine that has been taken up by the receiving synapse (postsynapse) and then released back into the synaptic cleft so that it can be stored in the vesicles for reuse. DAT can also work in reverse, releasing dopamine from the cytoplasm into the extracellular space (DAT efflux).
If the DAT are too active or too many (which is often the case with ADHD), the DAT absorb the dopamine freshly released into the synaptic cleft by the transmitting synapse before it has been able to transmit the signal at the postsynapse. This leads to signal transmission disorders.

Dysregulation of DAT and VMAT can increase dopamine in the cell fluid, which can trigger auto-oxidation, the formation of ROS (reactive oxygen species = oxygen radicals) and the formation of neurotoxic quinones. Higher ROS levels can lead to oxidative stress.

Protein kinase C (PKC) reduces dopamine reuptake and DAT numbers.34 Mitogen-activated protein kinase (MAPK) pathways appear to activate the dopamine transporter (DAT). Striatal cells with particularly active MAPK showed increased dopamine reuptake, whereas in inhibited MAPK they correlated with decreased DA reuptake in a dose- and time-dependent manner.34 Increased DAT in HIV encephalitis

In those affected by neuropsychiatric disorders due to HIV infection, increased expression of DAT is assumed as a result of the resulting neuroinflammation,35 while unchanged DAT expression with reduced DAT activity was found in HIV without encephalitis. In addition, reduced levels of tyrosine hydroxylase and phosphorylated tyrosine hydroxylase were found. Furthermore, the D2 receptor was reduced and the D3 receptor was increased.36

IFN-α, given chronically, showed no change in DAT binding in monkeys.37

3.1.3. Reduced transmission of glutamate

IFN-γ (and, to a lesser extent, IFN-α) activate indoleamine 2,3-dioxygenase (IDO) in peripheral immune cells or microglia. IDO converts tryptophan to kynurenine, which is converted (by kynurenine aminotransferase) to kynurenic acid and quinolinic acid.15 Kynurenic acid acts as a glutamate receptor antagonist, which reduces glutamate neurotransmission. This in turn inhibits the release of dopamine in the striatum.
Excessive release of glutamate and quinolinic acid due to inflammation can increase oxidative stress and excitotoxicity.

This pathway is successfully treated with glutamate receptor antagonists such as ketamine.

A more detailed description can be found at How IFN-α triggers depression neurophysiologically In the section Depression and dysphoria in ADHD in the chapter Diagnostics

4. Inflammatory processes and serotonin

4.1. Cytokine effect on the serotonin system

IFN-γ and, to a lesser extent, IFN-α, reduce tryptophan, which is required for the synthesis of serotonin. IFN can therefore reduce serotonin levels.15

Stimulation of p38 mitogen-activated protein kinase (MAPK) can increase the expression and function of the serotonin transporter and thus serotonin reuptake, which can trigger serotonin deficiency.3839 MAPK and the serotonin transporter activation it mediates is activated by IL-1-β and TNF-α in a dose- and time-dependent manner and inhibited by IL-1-RA.38

BH4 is also required for the activities of tryptophan hydroxylase, which is a rate-limiting enzyme in the synthesis of serotonin. BH4 is therefore essential for the synthesis of serotonin, noradrenaline and dopamine (see above).
BH4 deficiency is a relevant pathway for understanding depression. If elevated IFN-alpha is detected, treatment with 5-HT, a prodrug of serotonin, could be recommended to counteract the impairment of tryptophan generation. We know of cases of treatment-resistant depression in which 5-HTP brought about an immediate improvement, at least temporarily. As 5-HTP is only converted to serotonin, 5-HTP is only helpful with regard to mood problems, but not with regard to ADHD symptoms, which are primarily caused by dopaminergic and noradrenergic factors.
One study suggests that tryptophan levels are reduced in adults with ADHD and that the degree of reduction in the level of tryptophan and its metabolites (= breakdown products) correlates with the severity of ADHD symptoms.40 Another study found that tryptophan levels tended to be higher in children with ADHD.41
Vitamin B12 supports the generation of tetrahydrobiopterin (BH4).

Endotoxin activates serotonin transporters (which can trigger a serotonin deficit) and reduces physical activity in mice in stress tests. The endotoxin-induced reduction in physical activity does not occur in mice with deactivated serotonin transporters and in mice whose IL-1 receptors were inhibited by an antagonist.42

  1. Mitchell, Goldstein (2014): Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review. J Am Acad Child Adolesc Psychiatry. 2014 Mar;53(3):274-96. doi: 10.1016/j.jaac.2013.11.013. METASTUDY of 67 Studies, n = 4.000

  2. van der Schans, Cao, Bos, Rours, Hoekstra, Hak, de Vries (2019): The temporal order of fluctuations in atopic disease symptoms and attention-deficit/hyperactivity disorder symptoms: a time-series study in ADHD patients. Eur Child Adolesc Psychiatry. 2019 Apr 24. doi: 10.1007/s00787-019-01336-2

  3. Lopes (2017): Why are behavioral and immune traits linked? Horm Behav. 2017 Feb;88:52-59. doi: 10.1016/j.yhbeh.2016.09.008.

  4. Dantzer, O’Connor, Freund, Johnson, Kelley (2008): From inflammation to sickness and depression: when the immune system subjugates the brain; Nature Reviews Neuroscience volume 9, pages 46–56, 2008

  5. Cole, Hawkley, Arevalo, Sung, Rose, Cacioppo (2007): Social regulation of gene expression in human leukocytes, Genome Biology 2007 8:R189. n = 14

  6. Vedhara, Gill, Eldesouky, Campbell, Arevalo, Ma, Cole (2015): Personality and gene expression: Do individual differences exist in the leukocyte transcriptome?, Psychoneuroendocrinology, Volume 52, 2015, Pages 72-82, ISSN 0306-4530, n = 121

  7. Leffa, Torres, Rohde (2018): A Review on the Role of Inflammation in Attention-Deficit/Hyperactivity Disorder. Neuroimmunomodulation. 2018;25(5-6):328-333. doi: 10.1159/000489635.

  8. Réus, Fries, Stertz, Badawy, Passos, Barichello, Kapczinski, Quevedo (2015): The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders, Neuroscience, Volume 300, 2015, Pages 141-154, ISSN 0306-4522,

  9. Allan, Rothwell (2001): Cytokines and acute neurodegeneration. Nature Reviews Neuroscience 2, 734–744, 2001

  10. Hassan, Noreen, Castro-Gomes, Mohammadzai, Batista Teixeira da Rocha, Landeira-Fernandez (2016): Association of Oxidative Stress with Psychiatric Disorders. Current Pharmaceutical Design, Volume 22, Number 20, 2016, pp. 2960-2974 15

  11. Sen, Duman, Sanacora (2008): Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications. Biological Psychiatry, Volume 64, Issue 6, 2008, Pages 527-532, ISSN 0006-3223,

  12. Pollak, Drndarski, Stone, David, McGuire, Abbott (2018): The blood–brain barrier in psychosis, The Lancet Psychiatry, Volume 5, Issue 1, 2018, Pages 79-92, ISSN 2215-0366,

  13. Kronfol, Remick (2000): Cytokines and the Brain: Implications for Clinical Psychiatry. American Journal of Psychiatry 2000 157:5, 683-694

  14. Miller, Raison (2016): The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nature Rev Immunol 2016; 16: 22-34

  15. Dunn (2006): Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res. 2006 Aug;6(1-2):52-68.

  16. Felger (2018): Imaging the Role of Inflammation in Mood and Anxiety-related Disorders, Curr Neuropharmacol. 2018 Jun; 16(5): 533–558. doi: 10.2174/1570159X15666171123201142

  17. Felger, Miller (2012): Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol. 2012 Aug;33(3):315-27. doi: 10.1016/j.yfrne.2012.09.003.

  18. Goldsmith, Haroon, Woolwine, Jung, Wommack, Harvey, Treadway, Felger, Miller (2016): Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder. Brain Behav Immun. 2016 Aug;56:281-8. doi: 10.1016/j.bbi.2016.03.025.

  19. Eisenberger, Berkman, Inagaki, Rameson, Mashal, Irwin (2010): Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry. 2010 Oct 15;68(8):748-54. doi: 10.1016/j.biopsych.2010.06.010.

  20. Pelsser, Buitelaar, Savelkoul (2009): ADHD as a (non) allergic hypersensitivity disorder: A hypothesis, Pediatric Allergy and Immunology, Volume 20, Issue 2,

  21. Yukawa, Iso, Tanaka, Tsubota, Owada-Makabe, Bai, Takeda, Akira, Maeda (2005): Down-regulation of dopamine transporter and abnormal behavior in STAT6-deficient mice. International Journal of Molecular Medicine 15, no. 5 (2005): 819-825.

  22. Besser, Ganor, Levite (2005): Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFα or both, Journal of Neuroimmunology, Volume 169, Issues 1–2, 2005, Pages 161-171, ISSN 0165-5728,

  23. Felger (2017): The Role of Dopamine in Inflammation-Associated Depression: Mechanisms and Therapeutic Implications. Curr Top Behav Neurosci. 2017;31:199-219. doi: 10.1007/7854_2016_13.

  24. Miller AH, Jones, Drake, Tian, Unger, Pagnoni (2014): Decreased Basal Ganglia Activation in Subjects with Chronic Fatigue Syndrome: Association with Symptoms of Fatigue. PLoS ONE 9(5): e98156.

  25. Felger, Li, Haroon, Woolwine, Jung, Hu, Miller (2016): Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry. Molecular Psychiatry volume 21, pages 1358–1365, 2016

  26. Neurauter, Schröcksnadel, Scholl-Bürgi, Sperner-Unterweger, Schubert, Ledochowski, Fuchs (2008): Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab. 2008 Sep;9(7):622-7.

  27. Haroon, Raison, Miller (2012): Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012 Jan;37(1):137-62. doi: 10.1038/npp.2011.205.

  28. Cunnington, Channon (2010): Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology Heart 2010;96:1872-1877.

  29. Xia, Tsai, Berka, Zweier (1998): Superoxide Generation from Endothelial Nitric-oxide Synthase A Ca2+/CALMODULIN-DEPENDENT AND TETRAHYDROBIOPTERIN REGULATORY PROCESS.The Journal of Biological Chemistry 273, 25804-25808.1998, doi: 10.1074/jbc.273.40.25804

  30. Kitagami, Yamada, Miura, Hashimoto, Nabeshima, Ohta (2003): Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood–brain barrier, Brain Research, Volume 978, Issues 1–2, 2003, Pages 104-114, ISSN 0006-8993,

  31. Li, Knowlton, Woodward, Habecker (2003): Regulation of noradrenergic function by inflammatory cytokines and depolarization. Journal of Neurochemistry, 86: 774-783. doi:10.1046/j.1471-4159.2003.01890.x

  32. Abreu, Llorente, Hernández, González (1994): Interleukin-1 beta stimulates tyrosine hydroxylase activity in the median eminence. Neuroreport. 1994 Jun 27;5(11):1356-8.

  33. Wikipedia: VMAT

  34. Morón, Zakharova, Ferrer, Merrill, Hope, Lafer, Lin, Wang, Javitch, Galli, Shippenberg (2003): Mitogen-Activated Protein Kinase Regulates Dopamine Transporter Surface Expression and Dopamine Transport Capacity. Journal of Neuroscience 17 September 2003, 23 (24) 8480-8488; DOI:

  35. Gelman, Spencer, HolzerI, Soukup (2006): Abnormal Striatal Dopaminergic Synapses in National NeuroAIDS Tissue Consortium Subjects with HIV Encephalitis, Journal of Neuroimmune Pharmacology, December 2006, Volume 1, Issue 4, pp 410–420

  36. Ferris, Mactutus, Booze (2008): Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev 32(5):883–909

  37. Felger, Mun, Kimmel, Nye, Drake, Hernandez, Freeman, Rye, Goodman, Howell, Miller (2013): Chronic Interferon-α Decreases Dopamine 2 Receptor Binding and Striatal Dopamine Release in Association with Anhedonia-Like Behavior in Nonhuman Primates, Neuropsychopharmacology volume 38, pages 2179–2187, 2013, n = 8

  38. Zhu, Blakely, Hewlett (2006): The Proinflammatory Cytokines Interleukin-1beta and Tumor Necrosis Factor-Alpha Activate Serotonin Transporters. Neuropsychopharmacologyvolume 31, pages2121–2131, 2006

  39. Zhu, Carneiro, Dostmann, Hewlett, Blakely (2005): p38 MAPK Activation Elevates Serotonin Transport Activity via a Trafficking-independent, Protein Phosphatase 2A-dependent Process. The Journal of Biological Chemistry 280, 15649-15658. doi: 10.1074/jbc.M410858200

  40. Aarsland, Landaas, Hegvik, Ulvik, Halmøy, Ueland, Haavik (2015): Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study. Behav Brain Funct. 2015 Nov 5;11(1):36. doi: 10.1186/s12993-015-0080-x.

  41. Oades, Dauvermann, Schimmelmann, Schwarz, Myint (2010): Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism–effects of medication. Behav Brain Funct. 2010 May 28;6:29. doi: 10.1186/1744-9081-6-29.

  42. Zhu, Lindler, Owens, Daws, Blakely, Hewlett (2010): Interleukin-1 Receptor Activation by Systemic Lipopolysaccharide Induces Behavioral Despair Linked to MAPK Regulation of CNS Serotonin Transporters. Neuropsychopharmacology volume 35, pages 2510–2520, 2010